| scholarly article | Q13442814 |
| P2093 | author name string | Atsushi Fujita | |
| Ryo Yamasaki | |||
| Hiroo Yamaguchi | |||
| Noriko Isobe | |||
| Jun-Ichi Kira | |||
| Mei Fang | |||
| Katsuhisa Masaki | |||
| Guangrui Li | |||
| P2860 | cites work | Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica | Q21132530 |
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Gap junction and hemichannel-independent actions of connexins on cell and tissue functions--an update | Q26851127 | ||
| Critical role of connexin 43 in secondary expansion of traumatic spinal cord injury | Q27863423 | ||
| Cyclooxygenase enzymes: catalysis and inhibition | Q28212483 | ||
| Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential | Q28218302 | ||
| Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11 | Q28254663 | ||
| Multiple sclerosis | Q28299151 | ||
| Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions | Q28366501 | ||
| Identification of cells expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord | Q28566575 | ||
| Connexin30 in rodent, cat and human brain: selective expression in gray matter astrocytes, co-localization with connexin43 at gap junctions and late developmental appearance | Q28576578 | ||
| Distinct permeation profiles of the connexin 30 and 43 hemichannels | Q28581350 | ||
| Effects of neural progenitor cells on post-stroke neurological impairment-a detailed and comprehensive analysis of behavioral tests | Q30594942 | ||
| Isolation of murine microglial cells for RNA analysis or flow cytometry | Q33283985 | ||
| Neurotoxic reactive astrocytes are induced by activated microglia | Q33602850 | ||
| Connexins regulate calcium signaling by controlling ATP release | Q33610043 | ||
| Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice | Q33769818 | ||
| Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection | Q33822879 | ||
| Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis | Q34021372 | ||
| Interleukin 1 in the brain: biology, pathology and therapeutic target | Q34117586 | ||
| Differential expression of three gap junction proteins in developing and mature brain tissues | Q34327171 | ||
| FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation | Q34490581 | ||
| Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15. | Q34494321 | ||
| Refined clinical scoring in comparative EAE studies does not enhance the chance to observe statistically significant differences. | Q50600452 | ||
| Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. | Q50628456 | ||
| Connexin 30 sets synaptic strength by controlling astroglial synapse invasion. | Q50683771 | ||
| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. | Q51735105 | ||
| Neurons control the expression of connexin 30 and connexin 43 in mouse cortical astrocytes. | Q51956086 | ||
| Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. | Q53278044 | ||
| Onset of secondary progressive phase and long-term evolution of multiple sclerosis | Q57912193 | ||
| P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis | Q58669617 | ||
| Natural history of secondary-progressive multiple sclerosis | Q59121739 | ||
| Gap junctional conductance is a simple and sensitive function of intracellular pH | Q71530735 | ||
| Connexin 43 gap junction proteins are up-regulated in remyelinating spinal cord | Q79722310 | ||
| Experimental allergic encephalomyelitis in connexin 43-heterozygous mice | Q80717776 | ||
| Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis | Q81342560 | ||
| Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction | Q83719801 | ||
| Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis | Q83770907 | ||
| Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity | Q84580749 | ||
| Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. | Q34632490 | ||
| Gap junctions and connexin expression in the normal and pathological central nervous system. | Q35059232 | ||
| Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives | Q35182733 | ||
| S100A expression in normal corneal-limbal epithelial cells and ocular surface squamous cell carcinoma tissue. | Q35189324 | ||
| Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity | Q35235779 | ||
| Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination | Q35815842 | ||
| Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE. | Q35928741 | ||
| Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation | Q36231523 | ||
| Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV. | Q36506531 | ||
| Astrocytic CX43 hemichannels and gap junctions play a crucial role in development of chronic neuropathic pain following spinal cord injury | Q36706186 | ||
| The role of connexins in controlling cell growth and gene expression | Q36803102 | ||
| Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes | Q36965917 | ||
| Excitatory and Inhibitory Neurons in the Hippocampus Exhibit Molecularly Distinct Large Dense Core Vesicles. | Q37218324 | ||
| Th1 cells downregulate connexin 43 gap junctions in astrocytes via microglial activation. | Q37483670 | ||
| IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia | Q37615661 | ||
| Connexin-based intercellular communication and astrocyte heterogeneity | Q38025823 | ||
| Gap-junction-mediated cell-to-cell communication | Q38039836 | ||
| Pathological mechanisms in progressive multiple sclerosis | Q38378846 | ||
| The S100A10-annexin A2 complex provides a novel asymmetric platform for membrane repair | Q39244179 | ||
| Allergic Inflammation Leads to Neuropathic Pain via Glial Cell Activation. | Q40459573 | ||
| Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial | Q40790707 | ||
| Human macrophage activation. Modulation of mannosyl, fucosyl receptor activity in vitro by lymphokines, gamma and alpha interferons, and dexamethasone | Q40918392 | ||
| Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity | Q41004144 | ||
| Connexin43 and connexin47 alterations after neural precursor cells transplantation in experimental autoimmune encephalomyelitis. | Q41011933 | ||
| Microglia Morphological Categorization in a Rat Model of Neuroinflammation by Hierarchical Cluster and Principal Components Analysis | Q41334335 | ||
| Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels | Q43854350 | ||
| Loss of astrocyte connexins 43 and 30 does not significantly alter susceptibility or severity of acute experimental autoimmune encephalomyelitis in mice | Q46197758 | ||
| Anti-inflammatory Microglia/Macrophages As a Potential Therapeutic Target in Brain Metastasis. | Q47132431 | ||
| CHD8 haploinsufficiency results in autistic-like phenotypes in mice | Q47394890 | ||
| Molecular cloning and functional expression of mouse connexin-30,a gap junction gene highly expressed in adult brain and skin | Q48062027 | ||
| Late onset and increasing expression of the gap junction protein connexin30 in adult murine brain and long-term cultured astrocytes. | Q48304354 | ||
| Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. | Q48328310 | ||
| Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter. | Q48579102 | ||
| Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS. | Q48607199 | ||
| Immunopathology of secondary-progressive multiple sclerosis. | Q48713004 | ||
| Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway. | Q49543789 | ||
| Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia. | Q49611742 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| microglia | Q1622829 | ||
| P304 | page(s) | 2588 | |
| P577 | publication date | 2018-11-07 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia | |
| P478 | volume | 9 |
Search more.